AIM
GH icon

ARK Investment Management’s Guardant Health GH Stock Holding History

ARK Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76M Buy
506,416
+19,741
+4% +$2.15M 0.49% 46
2026
Q1 		$45M Sell
486,675
-204,972
-30% -$20.6M 0.35% 53
2025
Q4 		$70.6M Sell
691,647
-103,587
-13% -$9.27M 0.47% 47
2025
Q3 		$49.7M Sell
795,234
-2,028,263
-72% -$110M 0.3% 56
2025
Q2 		$147M Buy
2,823,497
+1,414,381
+100% +$63.2M 1.08% 29
2025
Q1 		$60M Sell
1,409,116
-30,736
-2% -$1.33M 0.6% 35
2024
Q4 		$44M Sell
1,439,852
-72,842
-5% -$2.05M 0.37% 44
2024
Q3 		$34.7M Buy
1,512,694
+1,059,104
+233% +$30M 0.32% 52
2024
Q2 		$13.1M Buy
453,590
+92,424
+26% +$2.15M 0.12% 86
2024
Q1 		$7.45M Sell
361,166
-76,934
-18% -$1.65M 0.05% 115
2023
Q4 		$11.9M Sell
438,100
-135,223
-24% -$3.55M 0.07% 106
2023
Q3 		$17M Sell
573,323
-1,672
-0.3% -$58.8K 0.13% 86
2023
Q2 		$20.6M Sell
574,995
-8,260
-1% -$237K 0.14% 83
2023
Q1 		$13.7M Buy
583,255
+83,149
+17% +$2.37M 0.09% 92
2022
Q4 		$13.6M Sell
500,106
-42,007
-8% -$1.92M 0.12% 91
2022
Q3 		$29.2M Buy
+542,113
New +$27.8M 0.2% 68
2022
Q1 		– Sell
-82
Closed -$8K – 363
2021
Q4 		$8K Sell
82
-11
-12% -$1.14K ﹤0.01% 360
2021
Q3 		$12K Hold
93
– – ﹤0.01% 296
2021
Q2 		$12K Sell
93
-703,157
-100% -$94.6M ﹤0.01% 278
2021
Q1 		$107M Buy
703,250
+162,713
+30% +$24.6M 0.21% 92
2020
Q4 		$69.7M Buy
540,537
+306,516
+131% +$35.3M 0.19% 88
2020
Q3 		$26.2M Sell
234,021
-224,531
-49% -$20.5M 0.16% 73
2020
Q2 		$37.2M Buy
458,552
+210,901
+85% +$17M 0.4% 43
2020
Q1 		$17.2M Buy
247,651
+95,844
+63% +$7.35M 0.43% 44
2019
Q4 		$11.9M Buy
151,807
+77,604
+105% +$5.59M 0.3% 51
2019
Q3 		$4.74M Buy
74,203
+162
+0.2% +$14.3K 0.1% 76
2019
Q2 		$6.39M Buy
+74,041
New +$5.65M 0.16% 65

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ARK Investment Management's GH Position: Q2 2026 in Review

ARK Investment Management increased its Guardant Health (GH) stake by 4.1% in Q2 2026, buying an estimated $2.15M and bringing the position to 506,416 shares worth $76M. The position accounts for 0.49% of the portfolio, ranked #46.

ARK Investment Management first reported a position in GH in Q2 2019 and has held it in 27 quarters since. The position peaked at $147M in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • ARK Investment Management held 506,416 shares of Guardant Health worth $76M as of Q2 2026.
  • ARK Investment Management bought 19,741 Guardant Health shares in Q2 2026, an estimated $2.15M.
  • Guardant Health made up 0.49% of ARK Investment Management's portfolio in Q2 2026, its #46 holding.
  • ARK Investment Management first reported a position in Guardant Health in Q2 2019 and has held it in 27 quarters since.
  • ARK Investment Management's Guardant Health position peaked at $147M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.